Jetra Therapeutics
Jetra Therapeutics is a preclinical biotechnology company developing a novel engineered protein for the treatment of obesity-related liver diseases including non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitus (NASH). Jetra Therapeutics is a spin-out of the University of Queensland, founded on intellectual property developed at Mater Research Institute (MRI-UQ) and licensed by UQ’s technology transfer company, UniQuest.
7-day free trial · no credit card
Verified contacts
1
available on Kipplo
LinkedIn employees
2
1 to 10 range
Open roles
—
no listings
Distinct roles
1
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 1 verified contacts at Jetra Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
1 contacts with verified email or phone · masked until revealed.
Showing 1 of 1 verified contacts
Top roles at Jetra Therapeutics
1 distinct titles indexed · top 1 shown.
- 1non executive director
Sign up to unlock all 1 contacts at Jetra Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 1 verified contacts at Jetra Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.